Genus (CHIX:GNSL) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:GNSL Genus PLC CHIX:GNSL
70 GF Score
Price £22.62
GF Value £20.65
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Genus Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Genus is: Moderate Risk: Sensitive, better choose undervalued stock.

Genus  (CHIX:GNSl) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Genus Risk Assessment Related Terms

CHIX:GNSL vs VRTX, REGN, RVMD: Risk Assessment Comparison

For the Biotechnology subindustry, Genus's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genus Risk Assessment vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genus's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Genus's Risk Assessment falls into.


CHIX:GNSL
70GF Score
Genus PLC CHIX:GNSL
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genus (CHIX:GNSL) Overvalued in 2026?

Based on GuruFocus' analysis, Genus stock appears to be overvalued. The current stock price of £22.62 is trading 9.5% above its estimated GF Value™ of £20.65. GuruFocus considers Genus to be Fairly Valued.

Key valuation signals for CHIX:GNSL:

  • Risk Assessment:
  • GF Value™: £20.65 vs. price of £22.62 (9.5% above fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the CHIX:GNSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genus Business Description

Address Matrix House, Basing View, Basingstoke, Hampshire, GBR, RG21 4FF
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
70GF Score

Get the complete analysis for CHIX:GNSL

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£22.62
Price
£20.65
GF Value